V008-6813 Screening compound: 7-chloro-2-(4-methoxyphenyl)-4-[4-(2-methoxyphenyl)piperazin-1-yl]quinazoline

V008-6813 Screening compound: 7-chloro-2-(4-methoxyphenyl)-4-[4-(2-methoxyphenyl)piperazin-1-yl]quinazoline
V008-6813 Screening compound: 7-chloro-2-(4-methoxyphenyl)-4-[4-(2-methoxyphenyl)piperazin-1-yl]quinazoline alternative view

Chemical Structure Depiction of ChemDiv screening compound V008-6813
7-chloro-2-(4-methoxyphenyl)-4-[4-(2-methoxyphenyl)piperazin-1-yl]quinazoline

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V008-6813

Molecular Formula

C26H25ClN4O2 (C26 H25 ClN4 O2)

Compound Name

7-chloro-2-(4-methoxyphenyl)-4-[4-(2-methoxyphenyl)piperazin-1-yl]quinazoline

IUPAC name

7-chloro-2-(4-methoxyphenyl)-4-[4-(2-methoxyphenyl)piperazin-1-yl]quinazoline

SMILES

COc(cc1)ccc1-c1nc(N(CC2)CCN2c(cccc2)c2OC)c(ccc(Cl)c2)c2n1

InChI

InChI=1S/C26H25ClN4O2/c1-32-20-10-7-18(8-11-20)25-28-22-17-19(27)9-12-21(22)26(29-25)31-15-13-30(14-16-31)23-5-3-4-6-24(23)33-2/h3-12,17H,13-16H2,1-2H3

InChI Key

SRFRXAITRQWPCH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19787367

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

460.96

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

7.156

Distribution Coefficient, logD

6.715

Water Solubility, LogSw

-6.51

Polar Surface Area

39.772

Acid Dissociation Constant (pKa)

22.21

Base Dissociation Constant (pKb)

7.65

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

23.10

V008-6813 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin

References: we are preparing a list of scientific research reports with V008-6813 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V008-6813?
Check Price and Availability of V008-6813, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V008-6813 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V008-6813
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V008-6813
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V008-6813 available by request